CoChat

Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer

Open access
Shiao, Stephen L., Gouin, Kenneth H., Ing, Nathan, Ho, Alice, Basho, Reva, Shah, Aagam, Mebane, Richard H., Zitser, David, Martinez, Andrew, Mevises, Natalie-Ya, Ben-Cheikh, Bassem, Henson, Regina, Mita, Monica, McAndrew, Philomena, Karlan, Scott, Giuliano, Armando, Chung, Alice, Amersi, Farin, Dang, Catherine, Richardson, Heather, Shon, Wonwoo, Dadmanesh, Farnaz, Burnison, Michele, Mirhadi, Amin, Zumsteg, Zachary S., Choi, Rachel, Davis, Madison, Lee, Joseph, Rollins, Dustin, Martin, Cynthia, Khameneh, Negin H., McArthur, Heather, Knott, Simon R.V. · 2024 · Cancer Cell
Cited by 199

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Strategies are needed to better identify patients that will benefit from immunotherapy alone or who may require additional therapies like chemotherapy or radiotherapy to overcome resistance. Here we employ single-cell transcriptomics and spatial proteomics to profile triple negative breast cancer biopsies taken at baseline, after one cycle of pembrolizumab, and after a second cycle of pembrolizumab given with radiotherapy. Non-responders lack immune infiltrate before and after therapy and exhibit minimal therapy-induced immune changes. Responding tumors form two groups that are distinguishable by a classifier prior to therapy, with one showing high major histocompatibility complex expression, evidence of tertiary lymphoid structures, and displaying anti-tumor immunity before treatment. The other responder group resembles non-responders at baseline and mounts a maximal immune response, characterized by cytotoxic T cell and antigen presenting myeloid cell interactions, only after combination therapy, which is mirrored in a murine model of triple negative breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2023.12.012

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

Metadata

Authors
Shiao, S. L., Gouin, K. H., Ing, N., Ho, A., Basho, R., Shah, A., Mebane, R. H., Zitser, D., Martinez, A., Mevises, N.-Y., Ben-Cheikh, B., Henson, R., Mita, M., McAndrew, P., Karlan, S., Giuliano, A., Chung, A., Amersi, F., Dang, C., Richardson, H., Shon, W., Dadmanesh, F., Burnison, M., Mirhadi, A., Zumsteg, Z. S., Choi, R., Davis, M., Lee, J., Rollins, D., Martin, C., Khameneh, N. H., McArthur, H., & Knott, S. R. V.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2024-01
Volume
42
Issue
1
Pages
70-84.e8
ISSN
1535-6108 (ISSN-L)
OpenAlex
W4390674723
Cited by
199
References
30
FWCI
30.54
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.